Clinical Trials Browser

NCT07284849 2026-04-16

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

Phase 3 Recruiting

700 enrolled

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT06997497 2026-04-13

KANDLELIT-012

Phase 3 Recruiting

477 enrolled

Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT07222800 2026-04-08

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Phase 3 Recruiting

800 enrolled

Gastrointestinal

Colonic Diseases, Colonic Neoplasms, Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Intestinal Diseases, Intestinal Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Rectal Diseases, Colorectal Neoplasms

Clinical Trials

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

KANDLELIT-012

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

COnCERTO

ID-COMET

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer

A Study of Neoadjuvant QL1706 in Participants With Untreated dMMR/MSI-H Resectable Colon Cancer

ETHOS

The Sagittarius Trial

Localized Treatment Versus Palliative Chemotherapy in CRC Patients With 10 or More CRLM

MRD-GI

UMBRELLA

FOxTROT2France

Xian-Lian-Jie-Du Optimization Decoction As an Adjuvant Treatment for Prevention of Recurrence of Colon Cancer

CLAUDIA

ZJCH-CRCC-1

ADAGE

SPACE

Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers

CIRCULATE